iCAD, Inc.

iCAD, Inc. Global medical AI software leader. Creating a world where cancer can’t hide. With iCAD’s technology, cancer has finally met its match.

As a global medical technology leader providing innovative cancer detection and therapy solutions, our technologies empower clinicians worldwide with an arsenal of tools to detect cancer and stop it in its tracks – streamlining workflow, improving accuracy, and personalizing results like never before. The ProFound AI Breast Health Suite is the first, best, and only complete, triple-threat solution

that combines cancer detection, density assessment, and risk evaluation – all designed to accelerate discovery and improve outcomes. Our leading-edge cancer detection solution, ProFound AI®, is clinically proven to find cancers earlier and with greater accuracy, while slashing reading time for radiologists by more than half. PowerLook® Density Assessment simplifies and standardizes breast density reporting and stratification, offering consistent, accurate and reliable breast density categorization. And the latest addition to our Breast AI Suite, ProFound AI® Risk, is the world’s first clinical decision support tool that provides an accurate short-term breast cancer risk estimation that is truly personalized for each woman, based only on her mammogram. Our Xoft® Axxent® Electronic Brachytherapy (eBx®) System® is transforming the cancer treatment experience by empowering physicians to precisely and effectively target tumors anywhere in the body, anywhere in the world. Using the world’s smallest X-ray source, clinicians can precisely destroy disease while preserving healthy tissue, leaving cancer nowhere to hide. To learn more, visit www.icadmed.com.

Celebrating our 2-week anniversary today! 🎉 The iCAD and DeepHealth teams are collaborating, aligning on shared goals, a...
08/01/2025

Celebrating our 2-week anniversary today! 🎉 The iCAD and DeepHealth teams are collaborating, aligning on shared goals, and building momentum to advance breast health through AI and innovation.

We are excited for what’s ahead for health imaging, and know that we are stronger together. 💪

Together, we are creating a world where cancer can’t hide!

Learn More: https://bit.ly/4mczpxb

07/31/2025

[ ] Walk through this case from a screening mammogram that the radiologist was about to read as a BIRADS 2 (benign), but took a closer look due to the high case score from ProFound AI.

While exploring the scan more closely to see why there was a high case score, he saw enough irregular margins within one marked area to justify calling her back. In the spot CC, the lesion was much more pronounced. In the ultrasound, he found a 7mm mass with irregular margins buried in dense tissue, and it turned out to be a Grade 2 Invasive Ductal Carcinoma.

“I have to be frank on this case. Had I not had a high case score, that [mammogram] would not have triggered me to look at this spot and call this back. This 7mm cancer would have gone unnoticed for one year.”
- Dr. Chirag Parghi, Breast Radiologist

👉 Learn More about ProFound AI Detection: https://bit.ly/4kR3124

[ ] This 46-year-old woman with scattered fibroglandular densities for screening. Family history of breast cancer (mothe...
07/30/2025

[ ] This 46-year-old woman with scattered fibroglandular densities for screening. Family history of breast cancer (mother, age 66).

Screening DBT with group of BI-RADS category 4A coarse heterogeneous calcifications in left subareolar region. No masses on ultrasound. Pathology showed 12mm grade 2 DCIS that was ER+ PR+.

✨ ProFound AI Detection V4 integrated her prior exam, and it marked a case score of 81 and two marked lesion scores of 81 and 60 with zero false positives.

✨ Ask us to see more case studies! Let’s Connect: https://bit.ly/4o3CmSk

07/29/2025

It’s a great time to upgrade your breast AI detection solution! ✨ A 22% improvement in accuracy of finding small, hard-to-find cancers from ProFound AI V3 to V4 just means a great solution just got even better.

👉 Discover More: https://bit.ly/45i5pdx

There’s always a learning curve with any new software or process, but your dedicated iCAD team includes a Customer Succe...
07/28/2025

There’s always a learning curve with any new software or process, but your dedicated iCAD team includes a Customer Success Manager and experts with decades of combined mammography experience to walk you through every step.

Radiologists and the clinical care team meet directly with a product expert to train them within their live system, within their cases and workflows.

The personalized, expert-led training includes hands-on experience and a direct line to your trainer to ask follow-up questions that might arise about how to use ProFound AI.

👉 Learn More: https://bit.ly/3IJGd6W

07/25/2025

ProFound AI Detection got even more accurate and precise in Version 4! Cancer and non-cancer cases are stratified with more confidence, moving more of the non-cancer cases to lower score ranges and more of the cancer cases into higher ranges.

We’d love to talk to you about how our solutions can assist your radiologists to find cancer earlier.

Request a Demo: https://bit.ly/46bUAe7

07/24/2025

[ ] In this video case study by Dr. Nikki Gidwaney, a breast trained radiologist at Stony Brook Hospital in New York, walks through a case of a 66-year-old woman with scattered fibroglandular densities. ProFound Detection identified microcalcifications that were determined to be DCIS.

Watch Full Webinar: https://bit.ly/44BUivW

[ ] Areas of suspicion and grade 2 invasive ductal carcinoma and grade 2 DCIS detected using ProFound Detection v4 in Hi...
07/23/2025

[ ] Areas of suspicion and grade 2 invasive ductal carcinoma and grade 2 DCIS detected using ProFound Detection v4 in Highly Dense Breasts with no false positives.

✨ What tools are you using to help find breast cancer faster and earlier?

Let’s connect to see how our solutions can help!

Request a Demo: https://bit.ly/3IAwosc

AI is here to help your radiologist, not replace them. When it comes to your breast health, nothing replaces the experti...
07/22/2025

AI is here to help your radiologist, not replace them. When it comes to your breast health, nothing replaces the expertise of a skilled radiologist. But just like a second set of eyes, AI can help catch what’s easy to miss, especially in dense breast tissue.

AI doesn’t make decisions. It assists your care team by highlighting areas that may need a closer look, helping radiologists detect breast cancer earlier and with more confidence. It’s advanced technology working hand-in-hand with human expertise, all for your peace of mind.

✨ Ask your physician what tools their imaging center uses to help read your mammogram.

Learn More about AI-powered Mammography: https://bit.ly/40mIZ8q

07/21/2025

📢 Clinical Study finds that iCAD’s ProFound AI Enhances Detection and Accuracy in 3D Mammography. In this peer-reviewed clinical study by Dr. Joshua Nepute from Indiana University, et al, recently published in Clinical Breast Cancer, highlights the real-world impact of using ProFound AI in digital breast tomosynthesis (DBT).

THE RESULTS:
✅ Improved Cancer Detection
📈 Enhanced Diagnostic Accuracy
📉 Reduced False Positives

These results highlight the use of to support radiologists, improving performance across the board, with better detection, fewer unnecessary callbacks, and more confidence in every read.

“In our study, we show significant improvements in breast cancer detection, positive predictive values, specificity, and abnormal interpretation rates in a real-world clinical setting. Our findings align with previous works and confirm that AI support can be translated to the real-world with the potential to augment radiologist diagnostic accuracy in DBT screening programs. Importantly, the increased CDR did not compromise AIR; in fact, we observed a statistically significant decrease in AIR.”
* AIR – Abnormal interpretation rate
-- Nepute, et. al.

📄 Read the study: https://bit.ly/3IRRtOA

[ ] When Kettering Health reviewed their existing AI solutions, they discovered that some of their mammography units wer...
07/18/2025

[ ] When Kettering Health reviewed their existing AI solutions, they discovered that some of their mammography units were not supporting radiologists accurately. After upgrading to for DBT detection enterprise-wide, they saw an improvement in their radiologists’ clinical confidence and identifying even the most subtle, hard-to-detect cancers.

"ProFound AI is a game changer. Other AI technologies for DBT seem like smoke and mirrors when compared with ProFound AI. It is clearly the most advanced technology of its kind on the market, and we found it was going to fit well within the other components we offer in our screening program."
– Sally Grady, Former Director, Kettering Health Breast Centers

💻 View the Case Study & Webinar: https://bit.ly/44WZieA

Address

2 Townsend West, Suite 6
Nashua, NH
03063

Alerts

Be the first to know and let us send you an email when iCAD, Inc. posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to iCAD, Inc.:

Share